News Sentiment

INO sentiment intelligence

Inovio Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 46 Balanced news tone 65 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.18 Week of 10 Jul 2026
Weighted tone 46/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 12

high-authority source matches

Trend context Trend inactive

-3.3% over one week, +7.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

[EFFECT] INOVIO PHARMACEUTICALS, INC. SEC Filing

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -3.3% Price reacting lower
Trend fit Trend inactive 7.3% over four weeks
Fair value -73.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 45
Negative 13

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
MarketWatch 10
Market source 8
TradingView 6
Stock Titan 4
PR Newswire 4
TradingKey 3
simplywall.st 3
Ad Hoc News 3

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 21
Analyst action 3
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 65
Associated Press Direct company coverage

Inovio: Q1 Earnings Snapshot

Tone
Neutral 50/100
Event
Earnings
Published
13 May 2026 20:13
Source
Associated Press